David J. Clark
2019 - Aldeyra Therapeutics
In 2019, David J. Clark earned a total compensation of $2M as Former Chief Medical Officer at Aldeyra Therapeutics, a 64% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $148,556 |
|---|---|
| Option Awards | $1,359,210 |
| Salary | $424,445 |
| Stock Awards | $28,199 |
| Other | $11,200 |
| Total | $1,971,610 |
Clark received $1.4M in option awards, accounting for 69% of the total pay in 2019.
Clark also received $148.6K in non-equity incentive plan, $424.4K in salary, $28.2K in stock awards and $11.2K in other compensation.
Rankings
In 2019, David J. Clark's compensation ranked 5,999th out of 13,971 executives tracked by ExecPay. In other words, Clark earned more than 57.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,999 out of 13,971 | 57th |
Division Manufacturing | 2,248 out of 5,701 | 61st |
Major group Chemicals And Allied Products | 811 out of 2,200 | 63rd |
Industry group Drugs | 684 out of 1,886 | 64th |
Industry Pharmaceutical Preparations | 505 out of 1,398 | 64th |
Source: SEC filing on April 27, 2020.
Clark's colleagues
We found two more compensation records of executives who worked with David J. Clark at Aldeyra Therapeutics in 2019.